The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research.

To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages.

In this episode, host Dr. Narjust Florez moderates a discussion in Spanish about breakthrough advances in thoracic oncology presented at the conference with Dr. Jorge Alatorre Alexander and Dr. Miguel Gonzalez Velez.

Guests:

Jorge Alatorre Alexander, MD

Head of the Medical Oncology Service

National Institute of Respiratory Diseases (INER)

Miguel Gonzalez Velez, MD

Medical Oncologist

John Theurer Cancer Center at Hackensack University Medical Center

The 2026 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research.

To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages.

In this episode, host Dr. Clarissa Mathias moderates a discussion in Portuguese about breakthrough advances in thoracic oncology presented at the conference with Dr. Lilian Faroni and Dr. Vladmir Cordeiro de Lima.

Guests:

Lilian Faroni, MD, PhD

Radiation Oncologist

Oncologia D’Or Rio de Janeiro, Brazil

Vladmir Cordeiro de Lima, MD, PhD

Thoracic and Breast Oncologist

A.C. Camargo Cancer Center, São Paulo, Brazil

In this special WCLC 2026 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu recap key findings from day three of the conference, featuring major advances that move targeted therapies earlier in the treatment of lung cancer.

Guests Dr. Julia Rotow, Dr. Roy Herbst, and Dr. Daniel Tan discuss new data from DESTINY-Lung04, ADAURA, and REZILIENT3 and what these findings could mean for clinical practice.

Guests:

Dr. Julia Rotow

Clinical Director and Research Director, Lowe Center for Thoracic Oncology

Dana-Farber Cancer Institute

Dr. Roy Herbst

Director, Dartmouth Cancer Center

Professor, Geisel School of Medicine at Dartmouth

Dr. Daniel Shao-Weng Tan

Senior Consultant Medical Oncologist at Division of Medical Oncology, National Cancer Centre Singapore

Professor, Duke-NUS Medical School

Senior Clinician-Scientist, Genome Institute of Singapore

The 2026 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research.

To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages.

In this episode, host Dr. Chunxia Su moderates a discussion in Mandarin Chinese about breakthrough advances in thoracic oncology presented at the conference with Dr. Zhengfei Zhu, Dr. Yun Fan, and Dr. Dongsheng Yue.

Guests:

Dr. Yun Fan, MD, PhD

Chief Expert of the Multidisciplinary Lung Cancer Team, Zhejiang Cancer Hospital;

Senior Consultant (Grade II Chief Physician); Doctoral Supervisor

Dr. Dongsheng Yue, MD, PhD

Tianjin Medical University Cancer Institute and Hospital

Dr. Zhengfei Zhu, MD, PhD

Department of Radiation Oncology

Fudan University Shanghai Cancer Center

In this special WCLC 2026 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss daily highlights from the conference and ask what changes in clinic on Monday.

A ROS1 drug that protects the brain and a first line combination that could not beat a decade old standard. Dr. Alexander Drilon brings the first line ARROS-1 data on zidesamtinib, and Dr. Giannis Mountzios walks us through EVOKE-03, sacituzumab govitecan plus pembrolizumab in PD-L1 high lung cancer.

Guests:

Alexander Drilon, MD

Chief, Early Drug Development Service

Memorial Sloan Kettering Cancer Center

Professor, Weill Cornell Medical College

Attending Physician, Thoracic Oncology Service

Giannis Mountzios, MD, MSc, PhD

Medical Oncologist and Director at the 4th Oncology Department and Clinical Trials Unit

Henry Dunant Hospital Center

Athens, Greece,

From the IASLC 2026 World Conference on Lung Cancer (WCLC) in Seoul, Dr. Narjust Florez talks with Dr. Chad Rusthoven about MAVERICK, the trial that tested MRI surveillance alone against prophylactic cranial irradiation in small cell lung cancer, and with Dr. Chul Kim about the final overall survival results of PAPILLON, amivantamab plus chemotherapy in EGFR exon 20 insertion NSCLC.

Both guests share what patients and community oncologists should take from the data.

Guests:

Chul Kim, MD, MPH

Thoracic Medical Oncologist and Associate Professor

Georgetown University

Chad G. Rusthoven, MD

Adjunct Associate Professor

University of Colorado

University of North Carolina at Chapel Hill

Get ready for WCLC 2026 in Seoul with Lung Cancer Considered hosts Dr. Stephen Liu and Dr. Narjust Florez. From preparing for the flight and beating jet lag to navigating COEX, networking, exploring Seoul’s food scene, and making the most of the meeting, they share practical tips to help attendees arrive prepared and enjoy the full WCLC experience.

In this episode, Dr. Narjust Florez is joined by Dr. Yasir Elamin and Dr. Liliana Faroni to explore the evolving management of oligometastatic lung cancer. They break down key definitions, discuss when and how to use consolidative therapies like radiation and surgery, and examine patient selection, limitations, and emerging tools such as ctDNA that are shaping a more precise approach to care.

Guests:

Yasir Elamin, MD

Associate Professor of Thoracic Medical

University of Texas MD Anderson Cancer Center

Liliana Faroni, MD, PhD

Radiation Oncologist,

Oncologia D’Or Rio de Janeiro

In this Korean-language episode of Lung Cancer Considered, Dr. Chul Kim is joined by Dr. Hye-Ryun Kim and Dr. Young Kwang Chae to discuss the evolving role of immunotherapy across the lung cancer treatment continuum. They explore perioperative strategies for resectable NSCLC, treatment selection and biomarkers in advanced disease, emerging research, and what they are looking forward to at WCLC 2026 in Seoul.

Guest Host:

Chul Kim, MD, MPH

Thoracic Medical Oncologist and Associate Professor

Georgetown University

Guests:

Hye Ryun Kim, MD, PhD

Medical Oncologist

Chief of Lung Cancer Center

Yonsei Cancer Center

Young Kwang Chae, MD, MPH, MBA

Professor, Division of Hematology Oncology, Department of Medicine

Northwestern University Feinberg School of Medicine

Host Dr. Stephen Liu is joined by José Luis Castro, WHO Director-General Special Envoy for Chronic Respiratory Diseases, for a thought-provoking discussion on why lung cancer must be recognized as a global health priority. They explore the challenges of raising awareness, reducing stigma, expanding equitable access to lung cancer screening and care, and advancing the policies and partnerships needed to improve outcomes worldwide. The conversation also offers a preview of Castro's keynote message ahead of his appearance at the 2026 World Conference on Lung Cancer (WCLC) in Seoul this September.

Guest:

José Luis Castro

World Health Organization (WHO)

Director-General Special Envoy for Chronic Respiratory Diseases